Scoopfeeds — Intelligent news, curated.
Immix Biopharma stock rating maintained at Market Outperform by Citizens
business

Immix Biopharma stock rating maintained at Market Outperform by Citizens

Investing.com · May 11, 2026, 9:02 AM

Immix Biopharma stock rating maintained at Market Outperform by Citizens

Read full story on Investing.com → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop